Abuse resistant melt extruded formulation having reduced alcohol interaction

Details for Australian Patent Application No. 2009337886 (hide)

Owner Abbott GmbH & Co., KG

Inventors Roth, Wolfgang; Burst, Alexander; Zietsch, Martina

Agent Spruson & Ferguson

Pub. Number AU-A-2009337886

PCT Pub. Number WO2010/083894

Priority 12/359,788 26.01.09 US

Filing date 26 May 2009

Wipo publication date 29 July 2010

International Classifications

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/277 (2006.01)

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

Event Publications

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/083894 Priority application(s): WO2010/083894

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009337916-Gapped magnet core

2009337885-Weighted gaming chip and method of producing a chip of this type